Profil
Shane V.
Hegarty is the founder of Axonis Therapeutics, Inc. and held the title of Chief Scientific Officer.
Aktive Positionen von Shane V. Hegarty
| Unternehmen | Position | Beginn |
|---|---|---|
Axonis Therapeutics, Inc.
 Axonis Therapeutics, Inc. Medical/Nursing ServicesHealth Services Axonis Therapeutics, Inc. is a biotechnology company based in Cambridge, MA, committed to developing groundbreaking therapies for spinal cord injury and other currently incurable neurological disorders. The company is advancing two breakthrough discoveries, KCC2 upmodulation to reactivate spared tissue and PTEN inhibition to regenerate injured nerve connections, to make a real difference for patients, their families, and the healthcare system. The company was founded by Lisa McKerracher, Corey S. Goodman, Oswald Steward, Joanna Stanicka, Patrick J. Carew, Shane V. Hegarty, Bob Yant. Joanna Stanicka has been the CEO since incorporation. | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Axonis Therapeutics, Inc.
Axonis Therapeutics, Inc. Medical/Nursing ServicesHealth Services Axonis Therapeutics, Inc. is a biotechnology company based in Cambridge, MA, committed to developing groundbreaking therapies for spinal cord injury and other currently incurable neurological disorders. The company is advancing two breakthrough discoveries, KCC2 upmodulation to reactivate spared tissue and PTEN inhibition to regenerate injured nerve connections, to make a real difference for patients, their families, and the healthcare system. The company was founded by Lisa McKerracher, Corey S. Goodman, Oswald Steward, Joanna Stanicka, Patrick J. Carew, Shane V. Hegarty, Bob Yant. Joanna Stanicka has been the CEO since incorporation. | Health Services |
